Press
Office

Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.

Blog Categories

NEW CLINICAL RESEARCH: PULZE+ID DEMONSTRATE CREDENTIALS AS A VIABLE SMOKING ALTERNATIVE

We conducted a clinical trial with adult smoker volunteers to better understand the tobacco harm reduction potential of our heated tobacco system, Pulze & iD.

15 Jun 2023

Exploring the SAF: Post-Market Surveillance

In this series, we speak to Imperial scientists working in specific areas of our Scientific Assessment Framework, or SAF.

13 Jun 2023

Exploring the SAF: Computational Science

In this series, we speak to Imperial scientists working in specific areas of our Scientific Assessment Framework, or SAF.

22 May 2023

NEW IN-VITRO STUDY DEMONSTRATES BLU’S HARM REDUCTION POTENTIAL

New research suggests reduced levels of toxicants in our blu vapes are reflected in substantially reduced biological responses compared to cigarette smoke, in-vitro.

11 May 2023

Exploring the SAF: Behavioural Science

In this series, we speak to Imperial scientists working in specific areas of our Scientific Assessment Framework, or SAF.

17 Apr 2023

Exploring the SAF: Clinical Science

In this series, we speak to Imperial scientists working in specific areas of our Scientific Assessment Framework, or SAF.

29 Mar 2023

Showing 31 to 36 of 116 posts

Subscribe via Email